Papers
3
Total Citations
27
H-Index
3
About
Dr. Ke-Hung Tsui is a pioneering urologic surgeon whose research centers on advancing minimally invasive treatments for benign prostatic obstruction (BPO) and prostate cancer. His most cited work, a 2021 study with 16 citations, provides critical comparative outcomes for endoscopic enucleation of the prostate versus robotic-assisted simple prostatectomy in aging males with prostates larger than 80 cm³, directly informing surgical decision-making for complex cases. Dr. Tsui has also made notable contributions to nephron-sparing surgery, developing the innovative harmonic scalpel “drilling and clamping” method to achieve zero ischemic robotic-assisted partial nephrectomy—a technique that minimizes renal injury during small tumor resection. In high-risk prostate cancer, his 2014 investigation demonstrated that neoadjuvant hormone therapy followed by robotic-assisted radical prostatectomy yields favorable outcomes, addressing the persistent challenge of positive surgical margins and biochemical recurrence. With a focused portfolio spanning robotic urology, functional outcomes, and oncologic control, Dr. Tsui’s work continues to shape evidence-based urologic practice, offering patients safer, more effective surgical options.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3